Bailing Biological's application for IPO on the ChiNext Board of the Shenzhen Stock Exchange has been accepted. It is the largest supplier of ursodeoxycholic acid raw materials in China.

According to the AI Finance App, on June 9th, Zhongshan BaiLing Biotechnology Co., Ltd. (referred to as BaiLing Biotech) has submitted its application for an IPO on the ChiNext board of the Shenzhen Stock Exchange. Shenwan Hongyuan Securities is its sponsor and it plans to raise 867.11 million yuan.